Representative before the EPO

Company dna tibotec virco virology bvba
no operation time available
1 office
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Eva van Wanrooij has worked on the following 14 EPO patent applications which have been published in the last five years:

EP13700017

4,4-DISUBSTITUTED-1,4-DIHYDROPYRIMIDINES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/506, A61K 31/527, A61P 31/20, C07D 239/22, C07D 401/04, C07D 403/04, C07D 417/04, C07D 471/10, C07D 491/107
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11702842

COMPUTATION OF THE COMBINED POTENCY OF DRUG REGIMENS FROM FITTED OR IN VITRO DETERMINED DOSE-RESPONSE CURVES

IPC classification:
G06F 19/00
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP13727080

URACYL SPIROOXETANE NUCLEOSIDES

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/11
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
PATENT GRANTED
EP13756109

FUSED BICYCLIC SULFAMOYL DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/416, A61K 31/42, C07D 231/56, C07D 261/20
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
PATENT GRANTED
EP13756110

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/18, A61K 31/277, A61K 31/337, A61K 31/341, A61K 31/351, A61K 31/381, A61K 31/4164, A61K 31/4453, A61P 1/18, A61P 31/20, C07C 311/37, C07D 231/14, C07D 295/26, C07D 309/14, C07D 333/46
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP13756113

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/18, A61K 31/337, A61K 31/341, A61K 31/351, A61K 31/4164, A61K 31/426, A61K 31/44, A61K 31/4453, A61K 31/4468, A61P 31/20, C07C 311/16, C07C 311/20, C07C 311/51, C07D 233/42, C07D 277/16, C07D 309/14
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP14707372

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/18, A61P 31/20, C07C 311/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
PATENT GRANTED
EP14714292

N-PHENYL-CARBOXAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
C07D 207/16, C07D 209/42, C07D 405/12, C07D 409/12, C07D 487/08
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
The patent has been granted
EP11727184

PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2-{2-[METHYL-(SULPHAMOYL)-AMINO]-ETHOXY}-ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID

IPC classification:
C07C 307/06, C07D 223/14, C07D 487/04
Applicant:
Janssen Research & Development Ireland
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14727752

SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/401, A61P 31/00, C07D 207/40
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP11785634

URACYL SPIROOXETANE NUCLEOSIDE PHOSPHORAMIDATES

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/06
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11740622

HETERO-BICYCLIC DERIVATIVES AS HCV INHIBITORS

IPC classification:
A61K 31/47, A61K 31/4704, A61P 31/12, C07D 401/14, C07D 403/14, C07D 417/14, C07D 471/04, C07D 491/10
Applicant:
Janssen Research & Development Ireland
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11781797

URACYL SPIROOXETANE NUCLEOSIDE PHOSPHORAMIDATES

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/06
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
PATENT GRANTED
EP15704502

SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
C07D 401/12, C07D 405/14
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature